Skip to Main Content

Paper Details

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.
Cell
386
2018
624 kb, AR, BRCA2, CDK12 mutation, DNA, DNA repair deficiencies, MYC, Metastatic Prostate Cancer, TP53, androgen, androgen receptor, cancers, castration-resistant prostate cancer, chromothripsis, intergenic enhancer region, lncRNAs, metastatic prostate cancer, patients, protein-coding regions, tandem duplications
Author NameAffiliation
David A QuigleyHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Paul Lloyd
Rahul Aggarwal
Joshi J AlumkalKnight Cancer Institute, Oregon Health & Science University
Adam Foye
Marc D Perry
Jin ZhangWashington University in St. Louis, MO USA Institute for Informatics (I(2))
Marcin CieslikUniversity of Michigan, USA Michigan Center for Translational Pathology ann arbor
Tomasz M BeerKnight Cancer Institute, Oregon Health & Science University
Thomas J GeorgeKnight Cancer Institute, Oregon Health & Science University, Oregon Health and Science University
Kim N ChiUniversity of British Columbia
Martin E GleaveUniversity of British Columbia
Amina ZoubeidiUniversity of British Columbia
Robert E ReiterJonsson Comprehensive Cancer Center, university of california los angeles, USA VA Greater Los Angeles Healthcare System
Matthew B RettigJonsson Comprehensive Cancer Center, university of california los angeles
Owen N Witteand Molecular Genetics at the David Geffen School of Medicine, university of california los angeles
Lawrence Fong
Jonathan Chou
Haolong Li
Hui Li
Luke A GilbertHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Primo N LaraUniversity of California Davis, USA Comprehensive Cancer Center
Christopher P EvansComprehensive Cancer Center, University of California Davis
Theodore C GoldsteinUSA UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California
Theodore C GoldsteinUSA UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California
Joshua M StuartUC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California
Joshua M StuartUC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California
Scott A TomlinsUniversity of Michigan ann arbor
Daniel E SprattUniversity of Michigan ann arbor
Phillip G FebboInc.
Serafim BatzoglouInc.
Housheng Hansen HePrincess Margaret Cancer Centre/University Health Network
Jiaoti HuangDuke University
Alexander W WyattUniversity of British Columbia
Alan AshworthHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Arul M ChinnaiyanUniversity of Michigan, USA Michigan Center for Translational Pathology, USA Howard Hughes Medical Institute, University of Michigan Medical School, USA Rogel Cancer Center ann arbor
Arul M ChinnaiyanUniversity of Michigan, USA Michigan Center for Translational Pathology, USA Howard Hughes Medical Institute, University of Michigan Medical School, USA Rogel Cancer Center ann arbor
Christopher A MaherMcDonnell Genome Institute, Washington University in St. Louis
Christopher A MaherMcDonnell Genome Institute, Washington University in St. Louis
Eric J SmallHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Felix Y FengHelen Diller Family Comprehensive Cancer Center, University of California san francisco
  • 1 - 41

Datasets